论文信息 - Melanoma expression analysis with Big Data technologies

Melanoma expression analysis with Big Data technologies

Universidad de Malaga. Campus de Excelencia Internacional Andalucia Tech. This work was funded in part by Grants TIN2014-58304-R (Ministerio de Ciencia e Innovacion) and P11-TIC-7529 and P12-TIC-1519 (Plan Andaluz de Investigacion, Desarrollo e Innovacion). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

[1] T. Graeber,et al. Host immunity contributes to the anti-melanoma activity of BRAF inhibitors. , 2013, The Journal of clinical investigation.

[2] Axel Hoos,et al. Ipilimumab plus dacarbazine for previously untreated metastatic melanoma. , 2011, The New England journal of medicine.

[3] A. Daud,et al. Melanoma immunotherapy , 2014, Cancer biology & therapy.

[4] D. Schadendorf,et al. Improved survival with ipilimumab in patients with metastatic melanoma. , 2010, The New England journal of medicine.

[5] G. Freeman,et al. Response to BRAF Inhibition in Melanoma Is Enhanced When Combined with Immune Checkpoint Blockade , 2014, Cancer Immunology Research.

[6] David C. Smith,et al. Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. , 2012, The New England journal of medicine.

[7] C. Drake,et al. Safety and activity of anti-PD-L1 antibody in patients with advanced cancer. , 2012, The New England journal of medicine.

[8] Antoni Ribas,et al. Safety and tumor responses with lambrolizumab (anti-PD-1) in melanoma. , 2013, The New England journal of medicine.

[9] T. Graeber,et al. BRAF inhibitor vemurafenib improves the antitumor activity of adoptive cell immunotherapy. , 2012, Cancer research.